Clinical Trial Update: Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating strategies to reduce malaria burden in HIV-infected pregnant women and HIV-exposed children; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Malaria

Snippet

Sponsor: University of California, San Francisco | Conditions: Malaria, Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED | Results posted: 2019-03-05